Where women's health meets evidence
Science with empathy
We build formulations the slow way — from clinical literature and prescriber insight, backed by analytical rigour at every step.
How a Lemonaid formulation is born
We do not start with a molecule looking for a market. We start with an unmet clinical need in women's health, and then work backwards to the safest, most tolerable and most affordable way to address it.
Evidence-led selection
Every active and dose is chosen from peer-reviewed literature specific to women’s physiology, not extrapolated from general population data.
Formulation science
Bioavailability, tolerability and patient adherence guide the choice of salt form, dosage form and packaging.
Clinician co-design
Fertility specialists, gynaecologists and physicians review formulations before a single pack is printed.
Continuous iteration
Prescriber feedback and post-market observations feed into every annual pipeline review.
Our pipeline at a glance
Each therapeutic area is anchored by a defined clinical problem and a documented set of actives.
| Therapeutic Area | Clinical Focus | Key Actives | Status |
|---|---|---|---|
| Fertility Support | Ovulatory function & oocyte quality | Myo-inositol, NAC, L-arginine, micronized progesterone | In market |
| Pregnancy Care | Maternal & fetal nutrition | Folate, DHA, iron, calcium, D3 | In market |
| Menstrual Health | Cycle regulation & bleeding control | Progestins, oestrogen combinations | In market |
| Menopause Care | Vasomotor symptoms & bone loss | Soy isoflavones, black cohosh, calcium | In market |
| Bone & Joint Health | Bone density protection | Calcium citrate, D3, vitamin K2-7 | In market |
| Vaginal & Urinary Health | Infection & flora restoration | Azoles, lactic acid, lactobacillus strains | In market |
| Wellness & Nutrition | Micronutrient correction | Iron, selenium, inositol, cholecalciferol | In market |
Summary is indicative and for informational purposes only. Refer to the approved product literature for complete prescribing information.
Six checks before we talk about a product
Nothing in our portfolio reaches a physician's desk without clearing each of these gates.
Published literature review
Systematic review of peer-reviewed evidence on safety, efficacy and dosing before any formulation decision.
Analytical validation
Assay, related substances, dissolution and uniformity of dosage units validated at partner facilities.
Stability assurance
Accelerated and long-term stability data generated and retained for every marketed batch family.
Clinician advisory board
A standing panel of obstetricians, fertility specialists and physicians that reviews our pipeline twice a year.
Regulatory alignment
Documentation maintained in line with Schedule M and applicable state licensing requirements.
Pharmacovigilance
Structured adverse event collection and reporting channel for all marketed formulations.